INS and diabetes mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial demonstrated that intensive medical treatment carries an increased risk of all-cause mortality, a 35% increased risk of cardiovascular mortality, and a greater risk of hypoglycemic events and weight gain of 10 kg compared to those on standard insulin therapy (10).